Mulder secures £500k in pre-seed funding led by SFC Capital to advance medical device traceability.
The pre-seed round was led by SFC Capital alongside support from Innovate UK.
Mulder is a medical technology startup that builds blockchain-powered platforms for regulatory compliance and product traceability. The company helps manufacturers navigate complex supply chains and compliance standards.
Mulder has raised £500k in a pre-seed funding round led by SFC Capital, with additional backing from an Innovate UK grant. The company will use the capital to develop its platform and prepare for upcoming pilot programmes.
The startup focuses on supply chain transparency and regulatory compliance for medical device manufacturers. Its blockchain platform addresses pressing industry demands driven by stringent new regulations and technological integrations.
From the founder
"Securing SFC as our first institutional investor is a significant validation of our vision."
Michelle Kuei
CEO at Mulder
Investor perspective
"Mulder is leading a transformation in compliance within the medical device industry, addressing a critical need for innovation in this space. We’re excited to back the team on their journey and believe they will reshape how the industry operates."
Niklas Föltz
Marketing & Communications Manager, SFC Capital
Use of funds
- 01Continue product development
.png)
